Literature DB >> 23073614

Hypertension and mild cognitive impairment.

Cristina Sierra1, Mónica Doménech, Miguel Camafort, Antonio Coca.   

Abstract

The brain is an early target for organ damage due to high blood pressure. Hypertension is the major modifiable risk factor for stroke and small vessel disease. It has been suggested that cerebral microvascular disease contributes to vascular cognitive impairment. The mechanisms underlying hypertension-related cognitive changes are complex and not yet fully understood. Both high and, especially in the elderly, low blood pressure (BP) have been linked to cognitive decline and dementia. There is some evidence that antihypertensive drug treatment could play a role in the prevention of cognitive impairment through BP control. The BP levels that should be targeted to achieve optimal perfusion while preventing cognitive decline are still under debate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073614     DOI: 10.1007/s11906-012-0315-2

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  74 in total

1.  Arterial stiffness, cognitive decline, and risk of dementia: the Rotterdam study.

Authors:  Mariëlle M F Poels; Marieke van Oijen; Francesco U S Mattace-Raso; Albert Hofman; Peter J Koudstaal; Jacqueline C M Witteman; Monique M B Breteler
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

Review 2.  Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications.

Authors:  Hans-Christian Koennecke
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

3.  Aortic stiffness is an independent predictor of fatal stroke in essential hypertension.

Authors:  Stéphane Laurent; Sandrine Katsahian; Céline Fassot; Anne-Isabelle Tropeano; Isabelle Gautier; Brigitte Laloux; Pierre Boutouyrie
Journal:  Stroke       Date:  2003-04-03       Impact factor: 7.914

Review 4.  Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications.

Authors:  Angelo Scuteri; Peter M Nilsson; Christopher Tzourio; Josep Redon; Stephane Laurent
Journal:  J Hypertens       Date:  2011-08       Impact factor: 4.844

5.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

6.  Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Larry B Goldstein; Cheryl D Bushnell; Robert J Adams; Lawrence J Appel; Lynne T Braun; Seemant Chaturvedi; Mark A Creager; Antonio Culebras; Robert H Eckel; Robert G Hart; Judith A Hinchey; Virginia J Howard; Edward C Jauch; Steven R Levine; James F Meschia; Wesley S Moore; J V Ian Nixon; Thomas A Pearson
Journal:  Stroke       Date:  2010-12-02       Impact factor: 7.914

7.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors:  Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal:  Arch Intern Med       Date:  2002-10-14

Review 8.  Blood pressure, systolic and diastolic, and cardiovascular risks. US population data.

Authors:  J Stamler; R Stamler; J D Neaton
Journal:  Arch Intern Med       Date:  1993-03-08

9.  Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; A Richey Sharrett; F Javier Nieto; Lori L Boland; David J Couper; Thomas H Mosley; Barbara E K Klein; Larry D Hubbard; Moyses Szklo
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

10.  Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.

Authors:  Hans-Christoph Diener; Ralph L Sacco; Salim Yusuf; Daniel Cotton; Stephanie Ounpuu; William A Lawton; Yuko Palesch; Reneé H Martin; Gregory W Albers; Philip Bath; Natan Bornstein; Bernard P L Chan; Sien-Tsong Chen; Luis Cunha; Björn Dahlöf; Jacques De Keyser; Geoffrey A Donnan; Conrado Estol; Philip Gorelick; Vivian Gu; Karin Hermansson; Lutz Hilbrich; Markku Kaste; Chuanzhen Lu; Thomas Machnig; Prem Pais; Robin Roberts; Veronika Skvortsova; Philip Teal; Danilo Toni; Cam VanderMaelen; Thor Voigt; Michael Weber; Byung-Woo Yoon
Journal:  Lancet Neurol       Date:  2008-08-29       Impact factor: 44.182

View more
  11 in total

1.  Chronic Physical Conditions, Multimorbidity, and Mild Cognitive Impairment in Low- and Middle-Income Countries.

Authors:  Ai Koyanagi; Elvira Lara; Brendon Stubbs; Andre F Carvalho; Hans Oh; Andrew Stickley; Nicola Veronese; Davy Vancampfort
Journal:  J Am Geriatr Soc       Date:  2018-02-10       Impact factor: 5.562

2.  High daytime and nighttime ambulatory pulse pressure predict poor cognitive function and mild cognitive impairment in hypertensive individuals.

Authors:  Iolanda Riba-Llena; Cristina Nafría; Josefina Filomena; José L Tovar; Ernest Vinyoles; Xavier Mundet; Carmen I Jarca; Andrea Vilar-Bergua; Joan Montaner; Pilar Delgado
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

3.  Cerebral angiography, blood flow and vascular reactivity in progressive hypertension.

Authors:  Yunxia Li; Qiang Shen; Shiliang Huang; Wei Li; Eric R Muir; Justin A Long; Timothy Q Duong
Journal:  Neuroimage       Date:  2015-02-27       Impact factor: 6.556

4.  Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults.

Authors:  Shanna L Burke; Tamara Cadet; Marlaina Maddux
Journal:  J Natl Med Assoc       Date:  2017-07-18       Impact factor: 1.798

Review 5.  The effects of hypertension on the cerebral circulation.

Authors:  Paulo W Pires; Carla M Dams Ramos; Nusrat Matin; Anne M Dorrance
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

Review 6.  Ambulatory blood pressure in stroke and cognitive dysfunction.

Authors:  Antonio Coca; Miguel Camafort; Mónica Doménech; Cristina Sierra
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 7.  Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly?

Authors:  Antonio Coca; Eila Monteagudo; Mónica Doménech; Miguel Camafort; Cristina Sierra
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-04-13

Review 8.  The Utility of Cerebrovascular Reactivity MRI in Brain Rehabilitation: A Mechanistic Perspective.

Authors:  Venkatagiri Krishnamurthy; Justin D Sprick; Lisa C Krishnamurthy; Jolie D Barter; Aaminah Turabi; Ihab M Hajjar; Joe R Nocera
Journal:  Front Physiol       Date:  2021-03-17       Impact factor: 4.566

9.  Elevated Soluble Vascular Cell Adhesion Molecule-1 Is Associated With Cerebrovascular Resistance and Cognitive Function.

Authors:  Achille E Tchalla; Gregory A Wellenius; Farzaneh A Sorond; Margaret Gagnon; Ikechukwu Iloputaife; Thomas G Travison; Thierry Dantoine; Lewis A Lipsitz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-04-01       Impact factor: 6.053

10.  Cognitive impairment and hypertension in older adults living in extreme poverty: a cross-sectional study in Peru.

Authors:  Maria Lazo-Porras; Victor Ortiz-Soriano; Miguel Moscoso-Porras; Fernando M Runzer-Colmenares; German Málaga; J Jaime Miranda
Journal:  BMC Geriatr       Date:  2017-10-26       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.